Matches in SemOpenAlex for { <https://semopenalex.org/work/W2791008074> ?p ?o ?g. }
- W2791008074 endingPage "e0006310" @default.
- W2791008074 startingPage "e0006310" @default.
- W2791008074 abstract "Background In Algeria, the treatment of visceral and cutaneous leishmanioses (VL and CL) has been and continues to be based on antimony-containing drugs. It is suspected that high drug selective pressure might favor the emergence of chemoresistant parasites. Although treatment failure is frequently reported during antimonial therapy of both CL and VL, antimonial resistance has never been thoroughly investigated in Algeria. Determining the level of antimonial susceptibility, amongst Leishmania transmitted in Algeria, is of great importance for the development of public health policies. Methodology/Principal findings Within the framework of the knowledge about the epidemiology of VL and CL amassed during the last 30 years, we sampled Leishmania isolates to determine their susceptibility to antimony. We analyzed a total of 106 isolates including 88 isolates collected between 1976 and 2013 in Algeria from humans, dogs, rodents, and phlebotomines and 18 collected from dogs in France. All the Algerian isolates were collected in 14 localities where leishmaniasis is endemic. The 50% inhibitory concentrations (IC50) of potassium antimony tartrate (the trivalent form of antimony, Sb(III)) and sodium stibogluconate (the pentavalent form of antimony, Sb(V)) were determined in promastigotes and intramacrophage amastigotes, respectively. The epidemiological cutoff (ECOFF) that allowed us to differentiate between Leishmania species causing cutaneous or visceral leishmaniases that were susceptible (S+) or insusceptible (S-) to the trivalent form of antimony was determined. The computed IC50 cutoff values were 23.83 μg/mL and 15.91 μg/mL for VL and CL, respectively. We report a trend of increasing antimony susceptibility in VL isolates during the 30-year period. In contrast, an increase in the frequency of S- phenotypes in isolates causing CL was observed during the same period. In our study, the emergence of S- phenotypes correlates with the inclusion of L. killicki (syn: L. tropica) isolates that cause cutaneous leishmaniasis and that have emerged in Algeria during the last decade. Conclusion/Significance Our results provide insight into the spatiotemporal dynamics of Leishmania antimony susceptibility in Algeria. We highlight the need for the future implementation of an effective methodology to determine the antimony susceptibility status of Leishmania isolates to detect the emergence of and prevent the dissemination of drug-resistant strains." @default.
- W2791008074 created "2018-03-29" @default.
- W2791008074 creator A5030631636 @default.
- W2791008074 creator A5030943832 @default.
- W2791008074 creator A5040588774 @default.
- W2791008074 creator A5043678054 @default.
- W2791008074 creator A5050209651 @default.
- W2791008074 creator A5055072447 @default.
- W2791008074 creator A5079686567 @default.
- W2791008074 creator A5091678548 @default.
- W2791008074 date "2018-03-21" @default.
- W2791008074 modified "2023-10-11" @default.
- W2791008074 title "Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria" @default.
- W2791008074 cites W151941690 @default.
- W2791008074 cites W1587431299 @default.
- W2791008074 cites W1957934977 @default.
- W2791008074 cites W1963877011 @default.
- W2791008074 cites W1969096316 @default.
- W2791008074 cites W1983422859 @default.
- W2791008074 cites W1983722360 @default.
- W2791008074 cites W1984489828 @default.
- W2791008074 cites W1985535620 @default.
- W2791008074 cites W1986889737 @default.
- W2791008074 cites W1997231586 @default.
- W2791008074 cites W2000191754 @default.
- W2791008074 cites W2000661267 @default.
- W2791008074 cites W2005354799 @default.
- W2791008074 cites W2007552089 @default.
- W2791008074 cites W2008791117 @default.
- W2791008074 cites W2009252032 @default.
- W2791008074 cites W2009743385 @default.
- W2791008074 cites W2017637883 @default.
- W2791008074 cites W2022808037 @default.
- W2791008074 cites W2023411386 @default.
- W2791008074 cites W2031722061 @default.
- W2791008074 cites W2036327310 @default.
- W2791008074 cites W2038039923 @default.
- W2791008074 cites W2039215936 @default.
- W2791008074 cites W2042209854 @default.
- W2791008074 cites W2042550506 @default.
- W2791008074 cites W2064640589 @default.
- W2791008074 cites W2065048984 @default.
- W2791008074 cites W2067332665 @default.
- W2791008074 cites W2069546292 @default.
- W2791008074 cites W2070116597 @default.
- W2791008074 cites W2074301488 @default.
- W2791008074 cites W2074316760 @default.
- W2791008074 cites W2077871855 @default.
- W2791008074 cites W2080415871 @default.
- W2791008074 cites W2080603087 @default.
- W2791008074 cites W2084420388 @default.
- W2791008074 cites W2088238276 @default.
- W2791008074 cites W2092430868 @default.
- W2791008074 cites W2095437805 @default.
- W2791008074 cites W2097709405 @default.
- W2791008074 cites W2106731080 @default.
- W2791008074 cites W2107915297 @default.
- W2791008074 cites W2118361133 @default.
- W2791008074 cites W2120307572 @default.
- W2791008074 cites W2125044300 @default.
- W2791008074 cites W2126683399 @default.
- W2791008074 cites W2127966501 @default.
- W2791008074 cites W2132371036 @default.
- W2791008074 cites W2132788729 @default.
- W2791008074 cites W2136707101 @default.
- W2791008074 cites W2139456667 @default.
- W2791008074 cites W2149000113 @default.
- W2791008074 cites W2150596924 @default.
- W2791008074 cites W2152686523 @default.
- W2791008074 cites W2158758064 @default.
- W2791008074 cites W2166738424 @default.
- W2791008074 cites W2170906690 @default.
- W2791008074 cites W2182711354 @default.
- W2791008074 cites W2296520086 @default.
- W2791008074 cites W2397370958 @default.
- W2791008074 cites W2401421408 @default.
- W2791008074 cites W2415526367 @default.
- W2791008074 cites W2418109427 @default.
- W2791008074 cites W2430958296 @default.
- W2791008074 cites W2435135302 @default.
- W2791008074 cites W2471297355 @default.
- W2791008074 cites W2482335179 @default.
- W2791008074 cites W2511865216 @default.
- W2791008074 cites W2584298728 @default.
- W2791008074 cites W2775643792 @default.
- W2791008074 cites W64840384 @default.
- W2791008074 cites W70041852 @default.
- W2791008074 cites W902343570 @default.
- W2791008074 doi "https://doi.org/10.1371/journal.pntd.0006310" @default.
- W2791008074 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5889277" @default.
- W2791008074 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29561842" @default.
- W2791008074 hasPublicationYear "2018" @default.
- W2791008074 type Work @default.
- W2791008074 sameAs 2791008074 @default.
- W2791008074 citedByCount "26" @default.
- W2791008074 countsByYear W27910080742018 @default.
- W2791008074 countsByYear W27910080742019 @default.
- W2791008074 countsByYear W27910080742020 @default.